05 11月 2020 by admin in UncategorizedComments Syros Pharmaceuticals Reports Third Quarter 2020 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
29 10月 2020 by admin in UncategorizedComments Centrexion Therapeutics Raises $40.5 Million and Adds Lilly and Exome Asset Management as New Investors
29 10月 2020 by admin in UncategorizedComments 琅铧医药与Bioprojet公司达成战略合作，获得发作性睡病治疗药物Wakix® (pitolisant)中国独家权益
24 10月 2020 by admin in UncategorizedComments Syros Presents Initial Data from Phase 1Clinical Trial of SY-5609
21 10月 2020 by admin in UncategorizedComments SAM WHITING, M.D., PH.D., joins TEMPEST as executive vice president and chief medical officer
20 10月 2020 by admin in UncategorizedComments Design Therapeutics Appoints Industry Veteran, Dr. João Siffert, as Chief Executive Officer
